Abstract:Objective To explore the diagnostic value of magnifying endoscopy combined with Mucin 2 (MUC2), Mucin 5AC (MUC5AC), Mucin 6 (MUC6) and CD10 in early gastric cancer.Methods Tissues and adjacent tissues ( ≥ 1 cm from tumor margin) of 127 patients with early gastric cancer who were scheduled for endoscopic submucosal dissection (ESD) treatment from May 2018 to May 2021 were selected. Early gastric cancer patients underwent magnifying endoscopy; immunohistochemical method was used to determine the protein expression of MUC2, MUC5AC, MUC6 and CD10. Analyze the accuracy of magnifying endoscopy in the diagnosis of early gastric cancer. Compare the expression of MUC2, MUC5AC, MUC6 and CD10 in gastric cancer tissues and adjacent tissues; analyze the sensitivity and specificity of magnifying endoscopy combined with MUC2, MUC5AC, MUC6 and CD10 in the diagnosis of early gastric cancer.Results Among 127 patients with early gastric cancer, 108 cases were diagnosed accurately by magnifying endoscopy, with an accuracy rate of 85.03% (108/127). The positive expression of MUC2 in cancer tissues (61.42%) was higher than that in adjacent tissues (11.81%) (P < 0.05). The positive expression of MUC5AC in cancer tissues (54.33%) was higher than that in adjacent tissues (14.17%) (P < 0.05). The positive expression of MUC6 in cancer tissues (48.03%) was higher than that in adjacent tissues (7.87%) (P < 0.05). The positive expression of CD10 in cancer tissues (73.23%) was higher than that in adjacent tissues (15.75%) (P < 0.05). The sensitivity and specificity of magnifying endoscopy combined with MUC2, MUC5AC, MUC6 and CD10 in the diagnosis of early gastric cancer were significantly higher than those of magnifying endoscopy, MUC2, MUC5AC, MUC6 and CD10 alone (P < 0.05).Conclusion Magnifying endoscopy combined with MUC2, MUC5AC, MUC6 and CD10 has a good diagnostic value in early gastric cancer, and the combined diagnosis can improve the sensitivity and specificity.